Masters Biopharma (India) Private Limited

Masters Biopharma (India) Private Limited - manufacturing in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U36912MH2011FTC222075 Incorporated 16 September 2011 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Foreign Private Limited Company manufacturing
Data last updated
Revenue · FY 2025
₹1.21 Cr
▼ 13% YoY
Net profit · FY 2025
₹6.81 Lakh
Net margin 5.6%
EBITDA · FY 2025
₹9.56 Lakh
EBITDA margin 7.9%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1.22 Lakh
Issued & subscribed
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Masters Biopharma (India) Private Limited

Data last updated:

Masters Biopharma (India) Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India, a subsidiary of Masters Pharmaceuticals Limited. It operates in the diversified operations segment of the manufacturing sector. It was incorporated on 16 September 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U36912MH2011FTC222075. Its GSTIN is 27AAHCM4344H1ZE (Maharashtra).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.22 Lakh. It is led by directors Uday Pratap Singh and Zulfikar Masters.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.21 Cr, a decline of 13% compared to the previous year. For the same year it recorded a net profit of ₹6.81 Lakh (net margin 5.6%) and EBITDA of ₹9.56 Lakh (EBITDA margin 7.9%).

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website masters-sp.com.

Company details

CIN U36912MH2011FTC222075
Registration Number 222075
Incorporation Date 16 September 2011
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Masters Pharmaceuticals Limited
Compliance Status Active Compliant

Contact details

Masters Biopharma (India) Private Limited's registered office is in Mumbai, Maharashtra. Its website is masters-sp.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Skyline Icon 7th Floor Cts No. 1628/A 162, Marol Village Chimatpada Jb Nagar Marol Andheri East, Mumbai, Maharashtra, India – 400059
  • Industry
    Manufacturing, Other, Manufacturing

To see the full contact details of Masters Biopharma (India) Private Limited, buy the company report.

Comprehensive company report
Masters Biopharma (India) Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Masters Biopharma (India) is support service to organizations. In detail, this covers placement agencies and hr management services.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
NSupport service to OrganizationsN2Placement agencies and HR management services

To see the full business activity and turnover split of Masters Biopharma (India) Private Limited, buy the company report.

Financials of Masters Biopharma (India) Private Limited

FY 2025 filings available

Masters Biopharma (India) Private Limited reported revenue of ₹1.21 Cr (down 13% YoY) for FY 2025.

Revenue · FY 2025
₹1.21 Cr ▼ 13%
Net profit · FY 2025
₹6.81 Lakh margin 5.6%
EBITDA · FY 2025
₹9.56 Lakh margin 7.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 13%
EBITDA CAGR growth
1 year
▲ 10%

Revenue fell 13% in the latest year. EBITDA rose 10% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹9.56 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹6.81 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin7.9%
Net Profit Margin5.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Masters Biopharma (India) Private Limited, buy the company report.

Board of directors of Masters Biopharma (India) Private Limited

Masters Biopharma (India) has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Uday Pratap SinghDirector28 May 20197 Years 5 MonthsCurrent
Zulfikar MastersDirector16 Sep 201115 Years 1 MonthsCurrent

Auditor

Masters Biopharma (India) Private Limited is audited by DEEPAK NAYAK & ASSOCIATES for the financial year 2017.

Auditor firmFinancial yearFirm registration number
DEEPAK NAYAK & ASSOCIATESFY 2017102241W

Shareholding

The shareholding of Masters Biopharma (India) Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Masters Biopharma (India) Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Masters Biopharma (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Masters Biopharma (India) has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAHCM4344H1ZEMaharashtraActive25 Mar 2021

To see the full GST registrations and return filing status of Masters Biopharma (India) Private Limited, buy the company report.

Recent activity

Masters Biopharma (India) Private Limited has 8 board changes on record since 2011: 2 appointments and 6 cessations. The latest: Arpita Parag Mehta ceased to be Director on 31 Jul 2020.

AGM
Masters Biopharma (India) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Masters Biopharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Arpita Parag Mehta ceased to be Director.
Ceased
Uday Pratap Singh ceased to be Additional Director.
Ceased
Anish Popatlal Shah ceased to be Director.
Appointed
Uday Pratap Singh was appointed as Director.
Ceased
Abhay Hanuman Abhyankar ceased to be Director.
Ceased
Girish Laxmikant Telang ceased to be Director.
Ceased
Gary James Hume Mccutcheon ceased to be Director.
Appointed
Zulfikar Masters was appointed as Director.
Incorporation
16 Sep 2011
Masters Biopharma (India) Private Limited was registered on 16 Sep 2011 with Roc Mumbai I & aged 15 years 1 month as per MCA records.

Frequently asked questions

Masters Biopharma (India) is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in other, within the manufacturing industry. It was incorporated on 16 September 2011 (15+ years old) and is registered under CIN U36912MH2011FTC222075.

Masters Biopharma (India) has 2 current directors:

The latest financial statements of Masters Biopharma (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Masters Biopharma (India) is 27AAHCM4344H1ZE, registered in Maharashtra.

The CIN (Corporate Identification Number) of Masters Biopharma (India) is U36912MH2011FTC222075. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Masters Biopharma (India) was incorporated on 16 September 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.

Arpita Parag Mehta ceased to be Director on 31 Jul 2020. Uday Pratap Singh ceased to be Additional Director on 30 Sep 2019. Anish Popatlal Shah ceased to be Director on 28 May 2019. Masters Biopharma (India) has 8 board changes on record in total.

Masters Biopharma (India) can be reached through the website masters-sp.com. Its registered office is in Mumbai, Maharashtra, India.

The registered office of Masters Biopharma (India) is at Skyline Icon 7th Floor Cts No. 1628A 162, Marol Village Chimatpada Jb Nagar Marol Andheri East, Mumbai, Maharashtra, India – 400059.

Masters Biopharma (India) operates in the manufacturing industry, in the other segment.